print








Print
phone

+82-42-930-8777


Intellectual Property

Bioneer owns a portfolio of patents and patent applications related to SAMiRNA technology, RNAi drugs/molecules for particular disease indications, and robust siRNA design algorithms. Bioneer's SAMiRNA core technology is protected within an extensive global intellectual property portfolio comprised of more than 40 patent applications and issued patents.


Patent table

No Title Application country Application date Application No. Date of Patent Patent No.
1 siRNA for Inhibiting Survivin Gene Expression KR 2005-10-26 10-2005-101375 2008-07-21 848665
2 Method of Inhibiting expression of target mRNA using siRNA consisting of nucleotide sequence complementary to said target mRNA KR 2007-06-05 10-2007-7012736 2011-01-04 1007346
3 US 2007-06-08 11/721303    
4 JP 2007-06-06 2007-545384 2011-01-28 4672021
5 EP 2005-12-08 05822149.0    
6 CN 2007-08-07 200580047832.8 2010-12-15 715606
7 Method of inhibiting expression of Target mRNA using siRNA considering alternative splicing of genes KR 2006-06-13 10-2006-052904 2008-01-08 794705
8 Method of preparing siRNAs for selective inhibition of target mRNA isotypes US 2007-06-12 12/304707    
9 siRNA-hydrophilic polymer conjugates for intracellular delivery of siRNA and method thereof KR 2006-12-05 10-2006-7025591 2009-02-05 883471
10 EP 2008-02-21 06783636.1    
11 AU 2008-02-13 2006280600 2012-05-03 2006280600
12 CA 2008-02-15 2619533    
13 CN 2008-03-26 200680035462.0    
14 JP 2008-02-15 2008-526882    
15 IN 2008-02-20 1491/DELNP/2008    
16 US 2007-01-09 11/651011    
17 Conjugate for gene transfer comprising oligonucleotide and hydrophilic polymer, polyelectrolyte complex micelles formed from the conjugate, and methods for preparation thereof US 2006-08-07 10/551466 2012-12-04 8324365
18 Gold-coated stent coated/plated the chemicals and oligo nucleotide binding gold-coated stent and process for producing the same KR 2007-06-19 10-2007-059828 2011-03-10 1023164
19 US 2008-06-16 12/665404 2012-09-11 8263106
20 EP 2008-06-16 8766347.2    
21 JP 2008-06-16 2010-513100 2013-04-26 5254325
22 CN 2008-06-16 200880020770.5 2013-06-12 101711170
23 siRNA conjugate and preparing method thereof KR 2009-05-14 10-2009-042297 2013-01-16 1224828
24 KR 2009-05-14 10-2012-0069988 2013-03-05 1241852
25 KR 2009-05-14 10-2012-0114011    
26 US 2010-05-13 13/319885    
27 US 2010-05-13 13/613071    
28 EP 2010-05-13 10775118    
29 EP 2013-03-15 13159602.5    
30 EP 2013-09-20 13185358.2    
31 JP 2010-05-13 2012-510752    
32 JP 2013-05-08 2013-098798    
33 CN 2010-05-13 201080021324.3    
34 CN 2010-05-13 201210301551.2    
35 CN 2013-04-25 201310147988.X    
36 CA 2010-05-13 2761794    
37 AU 2010-05-13 2010248239    
38 BR 2010-05-13 1012141-2    
39 IN 2010-05-13 2336/MUMNP/2011    
40 RU 2010-05-13 2011150787    
41 RU 2013-11-21 2013151977    
42 Stable antisense oligonucleotide conjugate and its manufacturing method KR 2011-12-15 10-2011-0135162    
43 Double stranded oligo RNA molecule with a targeting ligand and method of preparing the same KR 2012-01-05 10-2012-0001710    
44 New oligonucleotide conjugate and use thereof PCT 2012-12-14 PCT/KR2012/010967    
45 Nanoparticular double-stranded oligo RNA molecule with high efficacy and method of preparing the same KR 2012-01-05 10-2012-0001711    
46 PCT 2013-01-04 PCT/KR2013/000035    
47 Magnetic nanoparticles-SAMiRNA complex and method of preparing the same KR 2013-01-17 10-2013-0005335    
48 PCT 2013-01-17 PCT/KR2013/000360    
49 Improved nanoparticular oligonucelotide conjugates with high efficacy and method of preparing the same KR 2013-07-05 10-2013-0079309